Sulforaphane treatment for autism spectrum disorder

Simple item page
dc.contributor.authorMcGuinness, Greer
dc.contributor.authorKim, Yeonsoo
dc.date.accessioned2020-12-16T15:36:37Z
dc.date.available2020-12-16T15:36:37Z
dc.date.issued2020-06-26
dc.description.abstractAutism Spectrum Disorder (ASD) is defined as a neurodevelopmental condition characterized by social communication impairment, delayed development, social function deficit, and repetitive behaviors. The Center for Disease Control reports an increase in ASD diagnosis rates every year. This systematic review evaluated the use of sulforaphane (SFN) therapy as a potential treatment option for individuals with ASD. PubMed.gov, PubMed Central, Natural Medicines, BoardVitals, Google Scholar and Medline were searched for studies measuring the effects of SFN on behavior and cognitive function. All five clinical trials included in this systematic review showed a significant positive correlation between SFN use and ASD behavior and cognitive function. The current evidence shows with minimal side effects observed, SFN appears to be a safe and effective treatment option for treating ASD.den
dc.identifier.citationMcGuinness, G., & Kim, Y. (2020). Sulforaphane treatment for autism spectrum disorder: A systematic review. EXCLI Journal, 19, 892-903. https://doi.org/10.17179/excli2020-2487de
dc.identifier.issn1611-2156
dc.identifier.urihttp://hdl.handle.net/2003/39908
dc.identifier.urihttp://dx.doi.org/10.17877/DE290R-21798
dc.language.isoen
dc.publisherIfADo - Leibniz Research Centre for Working Environment and Human Factors, Dortmundde
dc.relation.ispartofseriesEXCLI Journal;Vol. 19. 2020, pp. 892-903
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectSulforaphaneen
dc.subjectAutism Spectrum Disorderen
dc.subjectGlucosinolatesen
dc.subjectTreatmenten
dc.subjectCAMen
dc.subject.ddc610
dc.titleSulforaphane treatment for autism spectrum disorderen
dc.title.alternativea systematic reviewen
dc.typeText
dc.type.publicationtypearticle
dcterms.accessRightsopen access
eldorado.dnb.zdberstkatid2132560-1
eldorado.dnb.zdberstkatidtrue
eldorado.identifier.urlhttps://www.excli.de/index.php/excli/article/view/2487

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
excli2020-2487.pdf
Size:
159.81 KB
Format:
Adobe Portable Document Format
Description:
DNB
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
4.85 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Review Articles 2020